CONMED Corp Research And Development Expense

• CONMED Corp showed an increase of +2.7% in Research And Development Expense from 2024 to 2025.
• This data is from CONMED Corp's annual report (Form 10-K), filed with the SEC on February 17, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), CONMED Corp's Research And Development Expense has grown by 75.5%.
• Historical annual values: Fiscal year 2025: $55.88 million | Fiscal year 2024: $54.43 million | Fiscal year 2023: $52.60 million | Fiscal year 2022: $47.15 million | Fiscal year 2021: $43.57 million | Fiscal year 2020: $40.47 million | Fiscal year 2019: $45.46 million | Fiscal year 2018: $42.19 million | Fiscal year 2017: $32.31 million | Fiscal year 2016: $32.25 million | Fiscal year 2015: $27.44 million | Fiscal year 2014: $27.78 million | Fiscal year 2013: $25.83 million | Fiscal year 2012: $28.21 million | Fiscal year 2011: $28.65 million | Fiscal year 2010: $29.65 million | Fiscal year 2009: $31.84 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026